The Underlying Pathology of Atherosclerosis: Different Players
- PMID: 35328656
- PMCID: PMC8953777
- DOI: 10.3390/ijms23063235
The Underlying Pathology of Atherosclerosis: Different Players
Abstract
Cardiovascular diseases (CDVs) are still the leading cause of mortality in the developed world, despite the high number of deaths caused by the COVID pandemic of the last two years [...].
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the development of this Special Issue, in the writing of this manuscript, or in the decision to publish it.
References
-
- Gonzalez-Guerra A., Roche-Molina M., García-Quintáns N., Sánchez-Ramos C., Martín-Pérez D., Lytvyn M., de Nicolás-Hernández J., Rivera-Torres J., Arroyo D.F., Sanz-Rosa D., et al. Sustained Elevated Blood Pressure Accelerates Atherosclerosis Development in a Preclinical Model of Disease. Int. J. Mol. Sci. 2021;22:8448. doi: 10.3390/ijms22168448. - DOI - PMC - PubMed
-
- Díez-Ricote L., Ruiz-Valderrey P., Micó V., Blanco-Rojo R., Tomé-Carneiro J., Dávalos A., Ordovás J.M., Daimiel L. Trimethylamine n-Oxide (TMAO) Modulates the Expression of Cardiovascular Disease-Related microRNAs and Their Targets. Int. J. Mol. Sci. 2021;22:11145. doi: 10.3390/ijms222011145. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
